Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma ; volume:3 ; number:1 ; day:21 ; month:4 ; year:2015 ; pages:1-6 ; date:12.2015
Journal for ImmunoTherapy of Cancer ; 3, Heft 1 (21.4.2015), 1-6, 12.2015
- Creator
-
Läubli, Heinz
- Contributor
-
Balmelli, Cathrin
Bossard, Matthias
Pfister, Otmar
Glatz, Kathrin
Zippelius, Alfred
SpringerLink (Online service)
- DOI
-
10.1186/s40425-015-0057-1
- URN
-
urn:nbn:de:1111-201610306210
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Läubli, Heinz
- Balmelli, Cathrin
- Bossard, Matthias
- Pfister, Otmar
- Glatz, Kathrin
- Zippelius, Alfred
- SpringerLink (Online service)
Other Objects (12)
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
Sex differences in macrophage polarization in experimental autoimmune myocarditis (EAM)
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
Sex differences in macrophage polarization in experimental autoimmune myocarditis (EAM)
Pembrolizumab as first-line treatment for metastatic uveal melanoma
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma
The impact of brain involvement in metastatic melanoma patients treated with Pembrolizumab [Abstract]
Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report
AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
Biopsy-proven autoimmune myocarditis in HIV-associated dilated cardiomyopathy
ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
Autoimmune comorbidities in patients with metastatic melanoma: a retrospective analysis of us claims data
Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report